Now showing items 1-1 of 1
Review: escitalopram—translating molecular properties into clinical benefit: reviewing the evidence in major depression
(SAGE Publications, 2010-02-10)
The majority of currently marketed drugs contain a mixture of enantiomers; however, recent evidence suggests that individual enantiomers can have pharmacological properties that differ importantly from enantiomer mixtures. ...